当前位置:首页 - 行情中心 - 康缘药业(600557) - 财务分析

康缘药业

(600557)

  

流通市值:76.04亿  总市值:76.04亿
流通股本:5.66亿   总股本:5.66亿

康缘药业(600557)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.80亿元,每股收益0.14元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益509255.03万元,未分配利润429557.90万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产688703.85万元,负债179448.82万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入831,272,696.533,292,900,188.282,342,688,380.581,641,577,928.56
营业总成本741,531,883.693,025,881,463.992,141,450,228.751,488,675,905.49
其他经营收益
营业利润96,638,900.15370,440,672.38259,963,533.5184,603,338.34
利润总额97,612,671.5356,566,100.69253,141,849.36180,782,407.71
净利润80,155,150.82307,304,612.7207,696,890.52148,708,370.27
每股收益
其他综合收益----
综合收益总额80,155,150.82307,304,612.7207,696,890.52148,708,370.27
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计3,206,404,269.443,313,117,580.483,301,633,408.473,449,387,243.71
非流动资产:
非流动资产合计3,680,634,207.933,549,478,185.033,438,616,941.083,383,999,307.84
资产总计6,887,038,477.376,862,595,765.516,740,250,349.556,833,386,551.55
流动负债:
流动负债合计1,657,317,508.531,721,173,275.31,652,177,202.41,790,750,758.95
非流动负债:
非流动负债合计137,170,713.88129,027,386.07175,285,765.19188,836,930.89
负债合计1,794,488,222.411,850,200,661.371,827,462,967.591,979,587,689.84
所有者权益(或股东权益):
归属于母公司股东权益合计4,897,782,580.334,818,506,632.424,714,217,561.424,656,945,168.31
股东权益合计5,092,550,254.965,012,395,104.144,912,787,381.964,853,798,861.71
负债和股东权益合计6,887,038,477.376,862,595,765.516,740,250,349.556,833,386,551.55
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计950,000,665.954,011,439,353.312,862,659,766.361,841,791,492.37
经营活动现金流出小计884,103,183.253,400,847,181.552,516,534,859.981,697,443,344.52
经营活动产生的现金流量净额65,897,482.7610,592,171.76346,124,906.38144,348,147.85
投资活动产生的现金流量:
投资活动现金流入小计9,764,026.24611,546,514.71495,891,643.64393,062,810.02
投资活动现金流出小计187,658,018.941,125,377,876.87829,263,338.82620,328,048.27
投资活动产生的现金流量净额-177,893,992.7-513,831,362.16-333,371,695.18-227,265,238.25
筹资活动产生的现金流量:
筹资活动现金流入小计----
筹资活动现金流出小计-116,391,555.3923,149,927.5523,172,212.9
筹资活动产生的现金流量净额--116,391,555.39-23,149,927.55-23,172,212.9
汇率变动对现金及现金等价物的影响-140,556.11-39,997.46-8,216.49-2,001.51
现金及现金等价物净增加额-112,137,066.11-19,670,743.25-10,404,932.84-106,091,304.81
期末现金及现金等价物余额2,035,973,677.982,148,110,744.092,157,376,554.52,061,690,182.53
补充资料:
现金及现金等价物的净增加额--19,670,743.25--106,091,304.81
最新报告期:2026-04-23
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
华泰证券代雯,唐庆雷,张云逸0.620.710.812026-04-23
TOP↑